IL86330A0 - Famotidine polymorphic forms and their preparation - Google Patents

Famotidine polymorphic forms and their preparation

Info

Publication number
IL86330A0
IL86330A0 IL86330A IL8633088A IL86330A0 IL 86330 A0 IL86330 A0 IL 86330A0 IL 86330 A IL86330 A IL 86330A IL 8633088 A IL8633088 A IL 8633088A IL 86330 A0 IL86330 A0 IL 86330A0
Authority
IL
Israel
Prior art keywords
preparation
famotidine
polymorphic forms
melting point
low
Prior art date
Application number
IL86330A
Other languages
English (en)
Original Assignee
Marga Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27240404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL86330(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ES8702020A external-priority patent/ES2009147A6/es
Priority claimed from ES8703326A external-priority patent/ES2015339A6/es
Priority claimed from ES8800888A external-priority patent/ES2017246A6/es
Application filed by Marga Investigacion filed Critical Marga Investigacion
Publication of IL86330A0 publication Critical patent/IL86330A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electron Beam Exposure (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IL86330A 1987-06-22 1988-05-10 Famotidine polymorphic forms and their preparation IL86330A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES8702020A ES2009147A6 (es) 1987-06-22 1987-06-22 Nuevo proceso para la preparacion de polimorfos de famotidina
ES8703326A ES2015339A6 (es) 1987-10-29 1987-10-29 Perfeccionamientos a la patente de invencion numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.
ES8800888A ES2017246A6 (es) 1988-03-23 1988-03-23 Mejoras a la patente de invencion, numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.

Publications (1)

Publication Number Publication Date
IL86330A0 true IL86330A0 (en) 1988-11-15

Family

ID=27240404

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86330A IL86330A0 (en) 1987-06-22 1988-05-10 Famotidine polymorphic forms and their preparation

Country Status (13)

Country Link
US (1) US5021582A (ko)
EP (1) EP0297019B1 (ko)
JP (1) JPH01100162A (ko)
KR (1) KR920000308B1 (ko)
CN (1) CN1030077A (ko)
AT (1) ATE69052T1 (ko)
AU (1) AU1767288A (ko)
CA (1) CA1322760C (ko)
DE (1) DE3865899D1 (ko)
DK (1) DK342988A (ko)
FI (1) FI882329A (ko)
IL (1) IL86330A0 (ko)
NO (1) NO882037L (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
DE69429119T2 (de) * 1993-07-09 2002-07-18 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
CN1196730A (zh) * 1996-06-19 1998-10-21 雷迪博士研究基金会 具有增强的抗糖尿病活性的穴糖酮的新的多晶型形式及其制备方法
JP4755789B2 (ja) * 2001-09-26 2011-08-24 株式会社フジシールインターナショナル ラベル及びその製造方法
CA2426122A1 (en) * 2002-05-02 2003-11-02 M/S Tonira Pharma Limited A process for the preparation of a combination of famotidine polymorphis a and b
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496737A (en) * 1982-09-27 1985-01-29 Merck & Co., Inc. Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) * 1986-06-20 1987-12-23 Uriach & Cia Sa J Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances

Also Published As

Publication number Publication date
KR890000086A (ko) 1989-03-11
FI882329A0 (fi) 1988-05-18
KR920000308B1 (ko) 1992-01-11
FI882329A (fi) 1988-12-23
DK342988A (da) 1988-12-23
NO882037D0 (no) 1988-05-10
AU1767288A (en) 1988-12-22
JPH01100162A (ja) 1989-04-18
CA1322760C (en) 1993-10-05
CN1030077A (zh) 1989-01-04
EP0297019A1 (en) 1988-12-28
NO882037L (no) 1988-12-23
ATE69052T1 (de) 1991-11-15
DK342988D0 (da) 1988-06-22
DE3865899D1 (de) 1991-12-05
US5021582A (en) 1991-06-04
EP0297019B1 (en) 1991-10-30

Similar Documents

Publication Publication Date Title
IT8522494A0 (it) Procedimento per la preparazione di formulazioni solide di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute.
DK166088A (da) Fremgangsmaade til fremstilling af kvaternaere esteraminer og anvendelse heraf
IL78831A0 (en) Hypoglycemic thiazolidine diones
EP0267155A3 (en) Bicyclic compounds
DK653688A (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
NO883506L (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
PH22556A (en) Heterocyclic compounds, pharmaceutical compositions containing the same and method of use thereof
OA09441A (fr) "Procédés de préparation de ptéridin-4(3H)-ones, et de compositions médicamenteuses les contenant".
IT8521763A0 (it) Procedimento per la preparazione di derivati 3-sostituiti dall'1-amino-2-idrossi-propano.
IL86330A0 (en) Famotidine polymorphic forms and their preparation
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
MA22154A1 (fr) Methode de preparation de derives de furo (3,4-c) pyridine sous forme non- racemique
FR2602771B1 (fr) Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent
DE58900821D1 (de) Verfahren zur herstellung von phosphororganischen derivaten des 2,4-di-t-butylphenols, der 4,4'-dihalogenmagnesium-verbindungen des biphenyls und die verwendung der phosphororganischen derivate zur stabilisierung von kunststoffen, insbesondere in polyolefinformmassen.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE3069275D1 (en) Synthesis of 1rs,4sr,5rs-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo(3.2.1)octane-1-acetic acid and intermediates
IT1218692B (it) Procedimento microbiologico per la preparazione di 9 alfa-idrossi-4-androstene-3,17 dione
IT8747655A0 (it) Metodo e composizione per migliorare il regime di crescita di animali
IT1216752B (it) Intermedi e procedimenti per lapreparazione di composti tetrazolici antipercolestorolemici.
DE19675008I2 (de) Verfahren zur Herstellung von Hylan und Hylanverbindungen.
NZ229300A (en) Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
IT8621066A0 (it) Procedimento per la preparazione di composti eterociclici azotati.
PT87743A (pt) Process for the preparation of pyrimidine derivatives and of insecticide and acaricide compounds which contain them
IT8723035A0 (it) Procedimento per la preparazione di n acilaniline.
IT1197856B (it) Procedimento per la preparazione di componenti antiruggine con migliorata scorrevolezza e penetrazione